Publications

Campesato LFelipe, Budhu S, Tchaicha J, Weng C-H, Gigoux M, Cohen IJose, Redmond D, Mangarin L, Pourpe S, Liu C et al..  2020.  Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.. Nat Commun. 11(1):4011.

Wang H, Franco F, Tsui Y-C, Xie X, Trefny MP, Zappasodi R, Mohmood SRaza, Fernández-García J, Tsai C-H, Schulze I et al..  2020.  CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.. Nat Immunol. 21(3):298-308.

Kluger HM, Tawbi HA, Ascierto ML, Bowden M, Callahan MK, Cha E, Chen HX, Drake CG, Feltquate DM, Ferris RL et al..  2020.  Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.. J Immunother Cancer. 8(1)

Zappasodi R, Budhu S, Abu-Akeel M, Merghoub T.  2020.  In vitro assays for effector T cell functions and activity of immunomodulatory antibodies.. Methods Enzymol. 631:43-59.

Sellam LSarah, Zappasodi R, Chettibi F, Djennaoui D, Mesbah NYahi-Ait, Amir-Tidadini Z-C, Touil-Boukoffa C, Ouahioune W, Merghoub T, Bourouba M.  2020.  Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism.. Arch Biochem Biophys. 690:108479.